Professor Chris Twelves, clinical director at the Leeds Teaching Hospitals NHS Trust NIHR Leeds CRF and Professor of Clinical Cancer Pharmacology and Oncology at the University of Leeds said: “This investigational cancer vaccine works by training the immune system to fight the cancer, which could be transformational for patients by slowing spread of the cancer and hopefully controlling their disease for longer.
Trending
- 'Overlooked cancer makes me fear for my daughters'
- Woman runs 126 miles in memory of 'one off' friend
- Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial
- Work, Money, & a Normal Life
- AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires
- HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia
- Mastectomy, ET Linked to Lower LRR in Young Populations With Breast Cancer
- Revolution Medicines previews ‘novel class’ of cancer treatments
Wednesday, April 22
